Fluzone
Fluzone is a biological therapy with 36 clinical trials. Currently 3 active trials ongoing. Historical success rate of 93.8%.
Success Metrics
Based on 30 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
6
Mid Stage
21
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
93.8%
30 of 32 finished
6.3%
2 ended early
3
trials recruiting
36
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Vaccine Responses in Patients With B Cell Malignancies
B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults
Systems Investigation of Vaccine Responses in Aging and Frailty
Adjuvanted Inactivated Vaccine Versus Inactivated Influenza Vaccine in Hutterite Children
Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP
Clinical Trials (36)
Vaccine Responses in Patients With B Cell Malignancies
B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults
Systems Investigation of Vaccine Responses in Aging and Frailty
Adjuvanted Inactivated Vaccine Versus Inactivated Influenza Vaccine in Hutterite Children
Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP
A Phase 2 Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu Vaccine
Comparison of Three Licensed Influenza Vaccines
The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection
Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029)
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age
Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children
Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children
B-cell Immunity to Influenza (SLVP017) - Years 2 (2010) & 3 (2011)
B-cell Immunity to Influenza (SLVP017)- Year 5, 2013
Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults
Comparative Study of Influenza Vaccines in Adults, FLUVACS-year 4
Immune Responses Induced by Different Licensed Influenza Vaccines
Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection (SLVP031)
Study to Evaluate the Safety, Tolerance and Immunogenicity of Fluviral™ in Healthy Adults
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 36